Our data revealed that survival improved from 10% to 90% in hepatocyte-conditioned Hmgb1-deficient mice with endotoxemia, which was also inconsistent with the findings of Huebener et al. (67). This evidence concerns the gene HMGB1 and serum lipopolysaccharide activity.